Allied Academic proudly announces “5th International Conference on Obesity & Weight Management” scheduled on November 20-21, 2019 in Berlin, Germany.
The main objective of the event is to promote awareness about proper nutrition and risk associated with improper diet along with obesity and its impact on health, Euro Obesity 2019 will apprise and support recent research on the several causes, results, treatment, and prevention of obesity. It includes an extensive series of Keynote presentations, Oral talks, Poster presentations, Symposium, Workshops, Exhibitions and Career development programs.
Euro Obesity 2019 aim is to gather the Researchers, Scientists, Practitioners, Therapists, Business Entrepreneurs, Biomedical companies, Healthcare Professionals, students, Industrial delegates, Directors, Board Members, Presidents, Vice Presidents, Deans and Head of the Departments, Pharmaceutical Companies, Drug Manufacturing Companies and Industries, Laboratory Technicians and Diagnostic Companies, Associations, Societies and Universities.
Obesity and weight management includes lifestyle alterations, medications or surgical procedure and the main treatment for obesity consists of dieting and physical exercise. Knowing what your body requirements is very important to weight management and may control over consumption and under consumption of food. It focuses on the long-term results that are completed through gentle weight loss, followed by retaining of an ideal weight for age, sex and height. Diet programs may create weight loss over the short term period, but maintaining this weight loss is frequently difficult and often requires making exercise and a lower calorie diet a stable part of an individual's lifestyle.
A person is more expected to develop obesity if one or both parents are obese. Genetics also affect hormones involved in fat regulation. For example, the deficiency of leptin which is one the genetic cause of obesity. Leptin is a hormone formed in fat cells and in the placenta. Leptin controls weight by signaling the brain to eat fewer when body fat stores are too high. If, for some reason, the body cannot produce enough leptin or leptin cannot signal the brain to eat less, this mechanism is lost, and obesity occurs. The role of leptin replacement as a treatment for obesity is under study.
Body mass index is strongly associated to diabetes and insulin resistance. In obese individuals, the amount of non-esterified fatty acids, glycerol, hormones, cytokines, proinflammatory markers, and other substances that are involved in the development of insulin resistance, is increased. The pathogenesis in the enlargement of diabetes is based on the detail that the ?-islet cells of the pancreas are impaired, causing a lack of regulation of blood glucose. The development of diabetes becomes more expected if the failure of ?-islet cells of the pancreas is accompanied by insulin resistance. Weight gain and body mass are central to the development and rising incidence of type 1 and type 2 diabetes.
Obesity increases the danger of many chronic and possibly lethal diseases. In general, the more body fat, the higher your health risk. However, the amount of weight gained throughout by an adult years also contributes to the risk. For example, a middle-aged person who weighs 10 kg more than they did in their early 20s has an increased possibility of high blood pressure, stroke, diabetes and coronary heart disease.
Obese people often have chronic low-level inflammation, which can cause DNA damage that leads to cancer. There are several areas of research which are exploring mechanisms that link obesity and cancer. Even with the limits of the study designs, there is consistent evidence that higher amounts of body fat are associated with increased risks of a number of cancers.
Childhood obesity is commonly a condition where excess body fat negatively affects a child’s health. Childhood obesity is dramatically increasing in prevalence, and the complications of obesity, previously only seen in adulthood, are beginning to appear in children for the first time. Until now, type 2 diabetes had only been described in adults and children from ethnic minorities. Childhood obesity is serious as a result of the extra pounds and might cause problems such as- inherited disorder, high force per unit area and high alcohol.
Eating disorders are complex mental illnesses. Some of eating disorders include bulimia, binge eating disorder and anorexia. There’s no single cause and people might not have all symptoms for any single eating disorder. Body size and eating disorders are interrelated. Larger body size is both a risk factor for developing an eating disorder and a common outcome for individuals with bulimia nervosa (BN) and binge eating disorder (BED). Body dissatisfaction and inappropriate dieting practices are linked to the development of eating disorders, obesity, and other problems.
PCOS is a common cause of infertility. Many women with PCOS are obese, but many thin women also carry the diagnosis. Despite widespread phenotypic heterogeneity and different underlying pathophysiology that may contribute to infertility, IVF is a common therapy for all infertile PCOS patients who fail ovulation induction. Some data in the literature suggests increasing weight decreases IVF success.
A gastrointestinal and hepatic disease, obesity is the direct cause or a significant risk factor. When obesity is a danger issue, it may interact with other mechanisms and result in earlier presentation or complicated diseases. Gastroenterologists are exclusively poised to participate in the multidisciplinary management of obesity as physicians caring for people with obesity-related diseases, in addition to their expertise in nutrition and endoscopic interventions. There are increased odds ratios or relative risks of several gastrointestinal complications of obesity. Gastroesophageal reflux disease, erosive esophagitis, Barrett’s esophagus, esophageal adenocarcinoma, erosive gastritis, gastric cancer, diarrhea, colonic diverticular disease, polyps, cancer, and liver disease including nonalcoholic fatty liver disease, cirrhosis, hepatocellular carcinoma, gallstones, acute pancreatitis, and pancreatic cancer.
Nutrition plays a major role in order to control obesity in individuals. Intake of a healthy diet is very vital to decrease obesity. There are several fat burning foods, which should be taken in order to fight against obesity. This means healthy diet is a great factor to be taken care by obese individuals. The fat burning foods include red pepper, whole grains, low fat dairy products, lean meats, green tea, etc.
Bariatric surgeries for example Gastric Bypass, Gastric Sleeve and LAP-BAND®, are all intended to address the cause of excess fat, rather than simply removing fat. Bariatric surgery can achieve long-term weight loss and is the greatest option for patients with a BMI of 30 or above.
Endocrine disorder that results when a gland produces too much or too little of an endocrine hormone, called a hormone imbalance. The endocrine system is a network of glands that produce and release hormones that help to regulate several main body tasks, including the body's ability to change calories into energy that powers cells and organs. It plays a significant role in whether or not develops diabetes, thyroid disease, growth disorders, sexual dysfunction, and a host of other hormone-related conditions.
Advanced interpretation and distinguishing tactics for obesity is needed that should be applicable, medically meaningful, and adds value to the health-promoting effects of weight loss. A conscious target is to start dynamic lifestyle changes by creating physical activity and consumption sound sustenance.
Obesity with comparison to physical disadvantage is as much as a psychological. Society views obesity very negatively and tends to believe that people World Health Organization are obese are ‘weak-willed’ and ‘unmotivated’. They understand social and work-related discrimination, sometimes suffer from low hollowness as a result, and feel uncomfortable with their bodies. Obese people are sometimes aware of these negative views, and initialize them, putting themselves at risk for disorders of mood, anxiety, and misuse. Obese people have mostly made multiple attempts to reduce weight, with very little or no success. Their unsuccessful attempts lead to discouragement, frustration, hopelessness, and learned helplessness concerning the prospect of losing weight within the future on their own.
About Euro Obesity 2019
Euro Obesity 2019 promotes awareness about proper nutrition and risk associated with improper diet along with obesity and its impact on health. It will encourage and support recent research on the several causes, results, treatment, and prevention of obesity. It includes Keynote presentations, Oral talks, Poster presentations, Symposia, Workshops and Exhibitions with Career development programs.
The main objective of Euro Obesity 2019 is to address the challenges in making a safer, sustainable and affordable system for medication, and health through consolidating the underpinning Medicine research platforms. To understand the depth of this subject it’s important to share knowledge with others due to newly generated problem. For that they need a platform to share their knowledge. We could say we create a golden opportunity for those people from all over the world to expose their knowledge through this conference. This specific gathering conduct introduction circulates data, conducts gatherings with present and potential researchers, make a sprinkle with new medication improvements, and get name acknowledgment at this 2-day occasion. World's prominent speakers, the latest restorative and demonstrative procedures, advancements, and the Novel advances and remedial measures for irresistible sicknesses anticipation and control are signs of this meeting. And it also focus in improving the lives of those who are living with obesity, cherishing careers of obesity scientists and practitioners and promoting the interdisciplinary nature of obesity research, management and education.
In addition to attending the conference, we invite you to experience Berlin, the beautiful and famous city in Germany, which attracts people from around the world.
Scientists, Doctors, Professors, Practitioners, Therapists, Business/Practice Managers, Health Professionals, Students, and Young researchers, Associations, Societies and Universities, Business Entrepreneurs, Biomedical companies, Healthcare Professionals, students, Industrial delegates, Directors, Board Members, Presidents, Vice Presidents, Deans and Head of the Departments, obesity Researchers, Pharmaceutical Companies, Drug Manufacturing Companies and Industries, Laboratory Technicians and Diagnostic Companies.
Disorders that may occur with obesity are Diabetes type 1and Diabetes type 2, asthma, sleep apnea, cardiovascular issues and orthopaedic problems. Almost 35% of the adults with income lower than $15000 per year are obese. 24% adults with income higher than $50000 per year are obese. Global Anti-obesity Drugs market is expected to grow at a CAGR of 39.45 % over the period 2014-2019.
Increment in the wellbeing issues, modern lifestyle and nearness of enormous number of obese populace over the globe is the driving element for the worldwide hostile to corpulence drug market. . The market is segmented by the product type and end user. The worldwide anti-obesity drug business sector is relied upon to develop at CAGR of 40% over the time of 2015-2020.The worldwide anti- obesity drug business sector is required to extend locally by North America, Europe and Asia pacific. The worldwide obesity surgery gadget business sector is relied upon to develop at a CAGR of 9.6% from 2014-2020 to come to an expected estimation of USD 2489.5 million in 2020 from USD 1432.4 in 2014. North America is the major business sector for international weight surgery devices took next by Europe.
Berlin, the German capital, is known for its exceptional form of attractions, its flourishing cultural scene and the way of life that is each fast and relaxed. Contrasts between historical buildings and modern architecture make the city apart from the rest. The sights of Berlin – from the geographic area Gate to the Federal government building – tell the story of a complete nation. A piece of Berlin, other than its excitement, is that the manner it ceaselessly reinvents itself. Berlin conjointly features a relaxed ambience and plenty of open areas for a breath of fresh air. No town in European country is greener than Berlin with its forests, lakes and sprawling parks.
Anti-obesity drug Growth by next 12 years
The anti-obesity drug market development will be driven by the quick uptake of novel rising specialists and the high pervasiveness of weight. As indicated by Global Anti-Obesity Drugs Market 2015-2019 exploration, the worldwide anti-obesity drugs business sector is set to develop at a CAGR of 39.45% over the period 2014-2019 Presently, the weight drug market comprises of not very many compelling medications, with constrained accessibility in various locales that is accessible in both the EU and the US. . U.S. is relied upon to burn through $344 billion on human services costs owing to heftiness in 2018 if rates keep on increasing at their present levels. The stoutness drug business sector will expand more than six-fold throughout the following decade, expanding from $420 million in 2010 to rate will reach at least 44% by 2030 in the United States, Ireland, France, Germany, Italy, Spain, the UK and Japan.
Importance and Scope:
Euro Obesity is anticipated to present an unresolved range of research from different nations carrying together united solutions. This Obesity congress will be of interest to anyone concerned in learning, sharing issues and experiences regarding Obesity & its related areas of Medicine & Health Care. This Obesity meeting fetches leading and experienced Metabolic and Bariatric Surgeons, Physicians, Basic and Clinical Research Scientists, Integrated Health Professionals, Registered Dieticians and Diabetes Educators, Physical Therapists, Students, Industry Professionals, Fitness Professionals and Health Promoters and many more.